EnzymeBioSystems Performance
The firm shows a Beta (market volatility) of 0.0, which means not very significant fluctuations relative to the market. the returns on MARKET and EnzymeBioSystems are completely uncorrelated.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days EnzymeBioSystems has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, EnzymeBioSystems is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors. ...more
| Fifty Two Week Low | 0.0001 | |
| Fifty Two Week High | 0.0001 |
EnzymeBioSystems |
EnzymeBioSystems Relative Risk vs. Return Landscape
If you would invest (100.00) in EnzymeBioSystems on April 27, 2025 and sell it today you would earn a total of 100.00 from holding EnzymeBioSystems or generate -100.0% return on investment over 90 days. EnzymeBioSystems is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than EnzymeBioSystems, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
EnzymeBioSystems Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for EnzymeBioSystems' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as EnzymeBioSystems, and traders can use it to determine the average amount a EnzymeBioSystems' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| ENZB |
Based on monthly moving average EnzymeBioSystems is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of EnzymeBioSystems by adding EnzymeBioSystems to a well-diversified portfolio.
EnzymeBioSystems Fundamentals Growth
EnzymeBioSystems Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of EnzymeBioSystems, and EnzymeBioSystems fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on EnzymeBioSystems Pink Sheet performance.
| Return On Equity | -278.28 | ||||
| Return On Asset | -144.51 | ||||
| Current Valuation | (390.86 K) | ||||
| Shares Outstanding | 5.59 M | ||||
| Price To Earning | (13.02) X | ||||
| Cash And Equivalents | 391.42 K | ||||
| Cash Per Share | 0.07 X | ||||
| Book Value Per Share | 0.07 X | ||||
| Cash Flow From Operations | (230.27 K) | ||||
| Earnings Per Share | (0.23) X | ||||
| Total Asset | 140 K | ||||
| Retained Earnings | (1.13 M) | ||||
| Current Asset | 140 K | ||||
| Current Liabilities | 4 K | ||||
Things to note about EnzymeBioSystems performance evaluation
Checking the ongoing alerts about EnzymeBioSystems for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for EnzymeBioSystems help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| EnzymeBioSystems is not yet fully synchronised with the market data | |
| EnzymeBioSystems has some characteristics of a very speculative penny stock | |
| EnzymeBioSystems has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (626.77 K). | |
| EnzymeBioSystems currently holds about 391.42 K in cash with (230.27 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.07. | |
| Roughly 46.0% of the company shares are held by company insiders |
- Analyzing EnzymeBioSystems' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether EnzymeBioSystems' stock is overvalued or undervalued compared to its peers.
- Examining EnzymeBioSystems' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating EnzymeBioSystems' management team can have a significant impact on its success or failure. Reviewing the track record and experience of EnzymeBioSystems' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of EnzymeBioSystems' pink sheet. These opinions can provide insight into EnzymeBioSystems' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in EnzymeBioSystems Pink Sheet
If you are still planning to invest in EnzymeBioSystems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the EnzymeBioSystems' history and understand the potential risks before investing.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |